Mendelian

📍 London, United Kingdom🗓 Founded 2015👥 22 employees💰 Last funded Feb 2020
Software Development🌐 mendelian.co
Website LinkedIn
At Mendelian, our mission is to make rare diseases our priority. We have an amazing team who have built software, which enables doctors to help patients earlier, by finding the undiagnosed. Did you know that rare diseases are not actually rare? More rare diseases are life-threatening condition that are collectively common. In fact, 1 in 17 of us will be affected by a rare disease in our lifetime. This is comparable to common diseases such as diabetes and asthma. Rare disease symptoms often develop gradually and in different organ systems. This means patients present to different doctors for seemingly independent reasons making these diseases difficult to diagnose. On average, rare disease patients experience 3 misdiagnoses, visit 5 different doctors and wait over 4 years before receiving a diagnosis in the UK. In the past decade, undiagnosed rare diseases have cost the NHS in excess of £3.4 billion.
5
Total investors
1
Early stage
4
Mid stage
0
Late stage
2015
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
Canada
1
Italy
1
Singapore
1
Greece
1
Investor activity2017–2020 · investors recorded per year
20171201812019120202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Mendelian?
Mendelian has 5 investors on record on gritt.io, including 1 early-stage backers, 4 mid-stage.
When did Mendelian last raise funding?
The most recent investment in Mendelian recorded on gritt.io was in February 2020.
When was Mendelian founded?
Mendelian was founded in 2015.
What industry is Mendelian in?
Mendelian operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Mendelian based?
Mendelian is headquartered in London, United Kingdom.